TrialBMC medicine2024

Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker.

Wen Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.